Author: admin

  • Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Baroness Thomas of Winchester on 2016-07-08.

    To ask Her Majesty’s Government, in the light of the result of the referendum on the UK’s membership of the EU, what plans they have for maintaining the UK’s status as a leader in EU and international collaboration on research into rare diseases such as muscular dystrophy and neuromuscular conditions.

    Baroness Neville-Rolfe

    The Government recognises the importance of our research base, which is why we have protected the ring fenced science resource budget in real terms from its current level of £4.7bn for the rest of the parliament. Programmes such as the £1.5bn Global Challenges Research Fund and the £1bn Ross Fund will support the UK’s status as a global leader in medical research.

    The Global Challenges Research Fund will mobilise the UK’s world leading research base to address key challenges facing developing countries, including in health research. The Ross Fund will develop, test and deliver a range of new products (including vaccines, drugs and diagnostics) to help combat the world’s most serious diseases in developing countries.

    The referendum result has no immediate effect on the right of researchers to apply to or participate in EU research programmes. UK participants can continue to apply to the programmes in the usual way. The future of UK access to these programmes will be determined as part of a wider discussion with the EU.

  • Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Baroness Thomas of Winchester on 2016-07-08.

    To ask Her Majesty’s Government, in the light of the result of the referendum on the UK’s membership of the EU, what measures they plan to take to ensure continued UK access to grants from Horizon 2020.

    Baroness Neville-Rolfe

    The UK economy is fundamentally strong and our research and innovation are world-leading. The UK’s decision to leave the EU has no immediate effect on the right of researchers to apply or to participate in Horizon 2020 as the UK is still an EU member state. UK participants can continue to apply to the programme in the usual way. The Commission has made a public statement on its website to this effect. The future of UK access to European research and innovation funding will be determined as part of wider discussions with the EU.

  • Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Baroness Thomas of Winchester on 2016-07-08.

    To ask Her Majesty’s Government, in the light of the result of the referendum on the UK’s membership of the EU, what measures they plan to take to ensure the UK’s continued participation in EU-wide data sharing initiatives for clinical trial development and condition-specific patient registries.

    Baroness Neville-Rolfe

    The Government recognises the importance of our research base, which is why we have protected the ring fenced science resource budget in real terms from its current level of £4.7bn for the rest of the parliament. Programmes such as the £1.5bn Global Challenges Research Fund and the £1bn Ross Fund will support the UK’s status as a global leader in medical research.

    The Global Challenges Research Fund will mobilise the UK’s world leading research base to address key challenges facing developing countries, including in health research. The Ross Fund will develop, test and deliver a range of new products (including vaccines, drugs and diagnostics) to help combat the world’s most serious diseases in developing countries.

    The referendum result has no immediate effect on the right of researchers to apply to or participate in EU research programmes. UK participants can continue to apply to the programmes in the usual way. The future of UK access to these programmes will be determined as part of a wider discussion with the EU.

  • Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department of Health

    Baroness Thomas of Winchester – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Thomas of Winchester on 2016-07-08.

    To ask Her Majesty’s Government, in the light of the result of the referendum on the UK’s membership of the EU, what plans they have for ensuring that the conditional approval of the European Medicines Agency for new treatments continues to have validity in the UK.

    Lord Prior of Brampton

    The previous Prime Minister was clear that the negotiation for Britain’s future relationship with Europe needed to begin under the new Prime Minister, and we now have got to look at all the detailed arrangements.

    The Department has launched a ministerial industry strategy group to prepare for the renegotiation on the new European Union/United Kingdom relationship, which includes looking at the relationship between the UK and the EU medicines regulatory framework.

  • Lord Turnberg – 2016 Parliamentary Question to the Department of Health

    Lord Turnberg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Turnberg on 2016-07-08.

    To ask Her Majesty’s Government, following the removal of the role of the National Clinical Director for gastrointestinal and liver diseases, what other forms of information and advice on those diseases are available to NHS England.

    Lord Prior of Brampton

    In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.

    Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.

    NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.

    Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.

  • Lord Turnberg – 2016 Parliamentary Question to the Department of Health

    Lord Turnberg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Turnberg on 2016-07-08.

    To ask Her Majesty’s Government whether NHS England will seek advice from specialist gastrointestinal disease societies following the removal of the role of National Clinical Director for that area.

    Lord Prior of Brampton

    In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.

    Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.

    NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.

    Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.

  • Lord Turnberg – 2016 Parliamentary Question to the Department of Health

    Lord Turnberg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Turnberg on 2016-07-08.

    To ask Her Majesty’s Government what mechanisms they plan to employ to seek advice on workforce planning for gastroenterology following the removal of the role of National Clinical Director for that area.

    Lord Prior of Brampton

    In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.

    Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.

    NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.

    Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.

  • Lord West of Spithead – 2016 Parliamentary Question to the Home Office

    Lord West of Spithead – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Lord West of Spithead on 2016-07-08.

    To ask Her Majesty’s Government whether they are investigating the use of University Royal Naval Unit craft and the Maritime Volunteer Service to increase the number of platforms available for security of UK territorial seas.

    Baroness Williams of Trafford

    Border Force and its partner organisations are well prepared to counter attempts by migrants to use small boats to circumvent border security and enter the UK illegally. A number of counter-measures have been put in place to detect and deter this activity, including the coordination of maritime security assets, so that maximum coverage at sea is delivered that ensures assets are in the right place at the right time.

  • Lord West of Spithead – 2016 Parliamentary Question to the Home Office

    Lord West of Spithead – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Lord West of Spithead on 2016-07-08.

    To ask Her Majesty’s Government whether the National Maritime Intelligence Centre has any command and control authority over assets available for security of UK territorial seas.

    Baroness Williams of Trafford

    The National Maritime Information Centre (NMIC) facilitates information exchange between government departments and agencies. Command and control of assets is administered by the respective organisations that are represented in the NMIC.

  • Paul Blomfield – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Paul Blomfield – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Paul Blomfield on 2016-07-07.

    To ask the Secretary of State for Business, Innovation and Skills, pursuant to the Answer of 13 June 2016 to Question 39359, on Business, Innovation and Skills reorganisation, what problems Ministers have encountered engaging with officials of his Department not based in London.

    Joseph Johnson

    I refer the hon. Member to the previous answer he references, in particular:

    “Operating across split sites, in the context of a smaller workforce overall, would make it harder to quickly redeploy people to a different team or policy area, or for someone to be able to respond to an unpredictable or unusual demand for more intensive engagement with Ministers or Parliament.”